Results 181 to 190 of about 49,971 (256)

Metabolic Phenotype Predicts Biochemical Response to Inositol Supplementation in Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis

open access: yesClinical Endocrinology, Volume 105, Issue 2, Page 237-244, August 2026.
ABSTRACT Objective To evaluate the effect of inositol supplementation on biochemical hyperandrogenism in women with polycystic ovary syndrome (PCOS) and to explore whether metabolic phenotype modifies the endocrine response. Design Systematic review and meta‐analysis of randomized controlled trials conducted in accordance with PRISMA guidelines ...
Daniele Tienforti   +10 more
wiley   +1 more source

Short‐Term Combined Treatment With Tirzepatide and Metformin for Overweight/Obese Chinese Women With Polycystic Ovary Syndrome: A Prospective, Open‐Label, Randomised Controlled Trial

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 7380-7392, August 2026.
ABSTRACT Aims This study aimed to assess the effects of low‐dose tirzepatide combined with metformin (COM) versus metformin (MET) monotherapy in overweight/obese women with polycystic ovary syndrome (PCOS). Materials and Methods Sixty overweight/obese women with PCOS were randomised to the MET group (1000 mg twice daily [BID]) or the COM group (MET ...
Zhuoran Yang   +7 more
wiley   +1 more source

Effectiveness of a 1‐h Reproductive Health Lecture on Enhancing Fertility Knowledge Among Japanese Female Undergraduates

open access: yesJournal of Obstetrics and Gynaecology Research, Volume 52, Issue 8, August 2026.
ABSTRACT Aim Despite growing public attention toward infertility treatments and elective oocyte cryopreservation, awareness of fertility among young adults remains limited. Accurate knowledge of age‐related fertility declines and ovarian reserve is particularly lacking in nonmedical populations. Providing accurate knowledge about reproductive health is
Tomomi Seki   +10 more
wiley   +1 more source

A Systematic Review and Meta‐Analysis of Semaglutide Effects on Adipose Tissue and Emerging Effects on Brain and Cognition

open access: yesObesity Reviews, Volume 27, Issue 8, August 2026.
ABSTRACT Background In 2023 and 2024, research into semaglutide (SEMA), an antiobesity and antidiabetic medication, indicated potential benefits beyond its approved uses, particularly in preventing Alzheimer's disease (AD). This highlights the link between obesity and AD development.
Amene Saghazadeh   +14 more
wiley   +1 more source

Androgen profiling in adolescent girls with polycystic ovary syndrome. [PDF]

open access: yesFront Endocrinol (Lausanne)
Zhang X   +10 more
europepmc   +1 more source

Blockade of FGFR1 Trafficking to the Cell Surface Results in the Partial Mistargeting of the Receptor to Peroxisomes

open access: yesThe FASEB Journal, Volume 40, Issue 13, 15 July 2026.
Fibroblast growth factor receptor 1 (FGFR1) is co‐translationally integrated into endoplasmic reticulum (ER) membranes and undergoes N‐glycosylation at several positions. This process is essential for FGFR1 progression through the secretory pathway.
Paulina Działek   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy